Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Clinical manifestations of seasonal influenza in adults

INTRODUCTION

Influenza is an acute respiratory illness caused by influenza A or B viruses that occurs in outbreaks and epidemics worldwide, mainly during the winter season. Signs and symptoms of upper and/or lower respiratory tract involvement are present, along with indications of systemic illness such as fever, headache, myalgia, and weakness. Although acutely debilitating, influenza is a self-limited infection in the general population (uncomplicated influenza); however, it is associated with increased morbidity and mortality in certain high-risk populations (complicated influenza).

The United States Centers for Disease Control and Prevention (CDC), in collaboration with the World Health Organization and its reporting network, tracks influenza virus isolates throughout the world to monitor disease activity and to predict the appropriate components for the annual influenza vaccine. Information, which is updated weekly, is available at the CDC web site.

The clinical manifestations of seasonal influenza in adults will be reviewed here. The clinical manifestations of this infection in children are discussed separately. The epidemiology, diagnosis, prevention, and treatment of seasonal influenza infection, as well as the clinical manifestations of pandemic H1N1 influenza ("swine influenza") and avian influenza, are reviewed elsewhere. (See "Seasonal influenza in children: Clinical features and diagnosis" and "Epidemiology of influenza" and "Diagnosis of seasonal influenza in adults" and "Seasonal influenza vaccination in adults" and "Prevention of seasonal influenza with antiviral drugs in adults" and "Infection control measures to prevent seasonal influenza in healthcare settings" and "Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')" and "Treatment of seasonal influenza in adults" and "Clinical manifestations and diagnosis of avian influenza".)

TRANSMISSION

Large amounts of influenza virus are often present in respiratory secretions of infected persons. As a result, infection can be transmitted through sneezing and coughing; influenza is thought to be transmitted primarily via large particle droplets (>5 microns) [1,2].

Acquisition via large particle droplets requires close contact with an infected individual, since large particles do not remain suspended in the air and travel only short distances (~6 feet) [3]. Limited data suggest that small particle respiratory droplets, which become aerosolized and stay suspended in the air for long periods, also contain influenza virus [4-7]. However, the contribution of small particles to airborne transmission of influenza is unclear. Contact with surfaces that have been contaminated with respiratory droplets is another potential source of transmission but is not a well-established mode of transmission. Although the respiratory tract is presumed to be the primary site for the acquisition of infection, one study has suggested that transocular entry of influenza virus can occur [8].

                 

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2014. | This topic last updated: Aug 20, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Mubareka S, Lowen AC, Steel J, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009; 199:858.
  2. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7:257.
  3. US Centers for Disease Control and Prevention. Interim guidance on the use of influenza antiviral agents during the 2010-2011 influenza season http://www.cdc.ov/flu/professionals/antivirals/guidance/summary.htm (Accessed on December 28, 2010).
  4. Blachere FM, Lindsley WG, Pearce TA, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009; 48:438.
  5. Wong BC, Lee N, Li Y, et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis 2010; 51:1176.
  6. Noti JD, Lindsley WG, Blachere FM, et al. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis 2012; 54:1569.
  7. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis 2013; 207:1037.
  8. Bischoff WE, Reid T, Russell GB, Peters TR. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011; 204:193.
  9. Cox NJ, Subbarao K. Influenza. Lancet 1999; 354:1277.
  10. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175.
  11. Killingley B, Enstone JE, Greatorex J, et al. Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis 2012; 205:35.
  12. World Health Organization Writing Group, Bell D, Nicoll A, et al. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006; 12:81.
  13. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775.
  14. Aoki FY, Boivin G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. J Clin Virol 2009; 44:255.
  15. Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509.
  16. Loeb M, Singh PK, Fox J, et al. Longitudinal study of influenza molecular viral shedding in Hutterite communities. J Infect Dis 2012; 206:1078.
  17. Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007; 28:1071.
  18. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492.
  19. Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172:1352.
  20. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26:1418.
  21. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis 2002; 34:E23.
  22. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39:1300.
  23. Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014; 58:214.
  24. Gooskens J, Jonges M, Claas EC, et al. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009; 199:1435.
  25. Lau LL, Ip DK, Nishiura H, et al. Heterogeneity in viral shedding among individuals with medically attended influenza A virus infection. J Infect Dis 2013; 207:1281.
  26. Nicholson KG. Clinical features of influenza. Semin Respir Infect 1992; 7:26.
  27. Dolin R. Influenza: current concepts. Am Fam Physician 1976; 14:72.
  28. KILBOURNE ED, LOGE JP. Influenza A prime: a clinical study of an epidemic caused by a new strain of virus. Ann Intern Med 1950; 33:371.
  29. Stuart-Harris, CH. Twenty years of influenza epidemics. Am Rev Respir Dis 1961; 83:54.
  30. Hall WJ, Douglas RG Jr, Hyde RW, et al. Pulmonary mechanics after uncomplicated influenza A infection. Am Rev Respir Dis 1976; 113:141.
  31. MARTIN CM, KUNIN CM, GOTTLIEB LS, et al. Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. AMA Arch Intern Med 1959; 103:515.
  32. Lyytikäinen O, Hoffmann E, Timm H, et al. Influenza A outbreak among adolescents in a ski hostel. Eur J Clin Microbiol Infect Dis 1998; 17:128.
  33. Muller NL, Franquet T, Lee KS, Silva CIS. Viruses, Mycoplasma, and Chlamydia. In: Imaging of Pulmonary Infections, Lippincott Williams and Wilkins, Philadelphia 2007. p.94.
  34. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002; 22 Spec No:S137.
  35. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA 2013; 309:275.
  36. Treanor JJ. Influenza virus. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2060.
  37. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005; 192:249.
  38. Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 2014; 16:55.
  39. Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127:1037.
  40. Bisno AL, Griffin JP, Van Epps KA, et al. Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic. Am J Med Sci 1971; 261:251.
  41. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009; 53:358.
  42. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.
  43. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.
  44. Dietzman DE, Schaller JG, Ray CG, Reed ME. Acute myositis associated with influenza B infection. Pediatrics 1976; 57:255.
  45. Dell KM, Schulman SL. Rhabdomyolysis and acute renal failure in a child with influenza A infection. Pediatr Nephrol 1997; 11:363.
  46. Cunningham E, Kohli R, Venuto RC. Influenza-associated myoglobinuric renal failure. JAMA 1979; 242:2428.
  47. Gamboa ET, Eastwood AB, Hays AP, et al. Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 1979; 29:1323.
  48. Abe M, Higuchi T, Okada K, et al. Clinical study of influenza-associated rhabdomyolysis with acute renal failure. Clin Nephrol 2006; 66:166.
  49. Naderi AS, Palmer BF. Rhabdomyolysis and acute renal failure associated with influenza virus type B infection. Am J Med Sci 2006; 332:88.
  50. Fujimoto S, Kobayashi M, Uemura O, et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet 1998; 352:873.
  51. Steininger C, Popow-Kraupp T, Laferl H, et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis 2003; 36:567.
  52. Goenka A, Michael BD, Ledger E, et al. Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. Clin Infect Dis 2014; 58:775.
  53. Bayer WH. Influenza B encephalitis. West J Med 1987; 147:466.
  54. Hjalmarsson A, Blomqvist P, Brytting M, et al. Encephalitis after influenza in Sweden 1987-1998: a rare complication of a common infection. Eur Neurol 2009; 61:289.
  55. Salonen O, Koshkiniemi M, Saari A, et al. Myelitis associated with influenza A virus infection. J Neurovirol 1997; 3:83.
  56. Rotbart HA. Viral meningitis. Semin Neurol 2000; 20:277.
  57. Sivadon-Tardy V, Orlikowski D, Porcher R, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis 2009; 48:48.
  58. Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis 2014; 58:1149.
  59. Ison MG, Campbell V, Rembold C, et al. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005; 40:415.
  60. Warren-Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011; 203:1710.
  61. Lichenstein R, Magder LS, King RE, King JC Jr. The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period. J Infect Dis 2012; 206:821.
  62. Warren-Gash C, Hayward AC, Hemingway H, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis 2012; 206:1652.
  63. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 2008; 130:304.
  64. Levenson JE, Kaul DR, Saint S, et al. Clinical problem-solving. A shocking development. N Engl J Med 2013; 369:2253.
  65. Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012; 205:895.
  66. MacDonald KL, Osterholm MT, Hedberg CW, et al. Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA 1987; 257:1053.
  67. Tolan RW Jr. Toxic shock syndrome complicating influenza A in a child: case report and review. Clin Infect Dis 1993; 17:43.